Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 47, 2017 - Issue 12
235
Views
14
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers

&
Pages 1035-1041 | Received 24 Jul 2016, Accepted 22 Sep 2016, Published online: 16 Nov 2016
 

Abstract

1. The purpose of the present study was to investigate the effect of piperine (PIP) on CYP2E1 enzyme activity and pharmacokinetics of chlorzoxazone (CHZ) in healthy volunteers.

2. An open-label, two period, sequential study was conducted in 12 healthy volunteers. A single dose of PIP 20 mg was administered daily for 10 days during treatment phase. A single dose of CHZ 250 mg was administered during control and after treatment phases under fasting conditions. The blood samples were collected at predetermined time intervals after CHZ dosing and analyzed by HPLC.

3. Treatment with PIP significantly enhanced maximum plasma concentration (Cmax) (3.14–4.96 μg/mL), area under the curve (AUC) (10.46–17.78 μg h/mL), half life (T1/2) (1.26–1.82 h) and significantly decreased elimination rate constant (Kel) (0.57–0.41 h 1), apparent oral clearance (CL/F) (24.76–13.65 L/h) of CHZ when compared to control. In addition, treatment with PIP significantly decreased Cmax (0.22–0.15 μg/mL), AUC (0.94–0.68 μg h/mL), T1/2 (2.54–1.68 h) and significantly increased Kel (0.32–0.43 h 1) of 6-hydroxychlorzoxazone (6-OHCHZ) as compared to control. Furthermore, treatment with PIP significantly decreased metabolite to parent (6-OHCHZ/CHZ) ratios of Cmax, AUC, T1/2 and significantly increased Kel ratio of 6-OHCHZ/CHZ, which indicate the decreased formation of CHZ to 6-OHCHZ.

4. The results suggest that altered pharmacokinetics of CHZ might be attributed to PIP mediated inhibition of CYP2E1 enzyme, which indicate significant pharmacokinetic interaction present between PIP and CHZ. The inhibition of CYP2E1 by PIP may represent a novel therapeutic benefit for minimizing ethanol induced CYP2E1 enzyme activity and results in reduced hepatotoxicity of ethanol.

Acknowledgements

The author, Satish Kumar Bedada would like thank University Grants Commission (UGC), New Delhi, India for financial support to carry out this research work.

Declaration of interest

The authors declare that there are no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.